F42 F10.2
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Age 18-65 • Assessed substance abuse disorder or OCD (ICD-10 or DSM-IV criteria) • Patient approves to be evaluated • Disorder was treated with a DBS • Patients have to be capable to give consent • Written informed consent
Exclusion criteria
Exclusion criteria: • paranoide-hallucinatory episode in the last 6 months • current depressive disorder • current organic or pharmacological psychotic episode • pregnancy or breast-feeding • suicidal tendencies or violent behaviour in the last six weeks • serious or instable physical disease or brain tumor • clinical relevant internal or neurological disease • Withdrawal of informed consent • FDG-PET contradiction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of impulsivity will be assesed with a delay discounting paradigma which results in a k-parameter (a high k-paramater indicates high impulsivity and a low k-parameter indicates low impuslvity) and the the baseline k-parameter (assesment before operation) will be compared to the acute effects of the on/off condition. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of resting-state metabolism will be assessed with FDG-PET. Effects of modulation shall be visualised by comparing the on and off condition. | — |
Countries
Germany
Contacts
Uniklinik KölnKlinik für Psychiatrie und Psychotherapie